| 2022 | Identification of a novel gene signature in second-trimester amniotic fluid for the prediction of preterm birth
| SCIENTIFIC REPORTS |
| 2021 | CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
| CANCER GENOMICS & PROTEOMICS |
| 2021 | LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
| AUTOPHAGY |
| 2021 | Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
| EXPERIMENTAL AND THERAPEUTIC MEDICINE |
| 2021 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial | LANCET ONCOLOGY |
| 2021 | Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2021 | The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical Cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY |
| 2021 | Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma
| MOLECULAR ONCOLOGY |
| 2021 | MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors
| PLOS PATHOGENS |
| 2020 | Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer
| CANCERS |
| 2020 | TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels
| CANCERS |
| 2020 | Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer
| CANCER GENOMICS & PROTEOMICS |
| 2020 | HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
| NATURE COMMUNICATIONS |
| 2019 | Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer
| BMC CANCER |
| 2019 | Clear Cell Carcinoma Arising from Endometriosis at the Cesarean Scar Site: A Case Report
| Archives of Clinical and Medical Case Reports |
| 2019 | Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer | Cancer genomics & Proteomics |
| 2019 | ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
| CANCERS |
| 2019 | Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
| 2019 | Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
| CANCER RESEARCH AND TREATMENT |
| 2018 | Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2018 | Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer
| BIOMED RESEARCH INTERNATIONAL |
| 2018 | Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
| Obstetrics & Gynecology Science |
| 2018 | Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
| PLOS ONE |
| 2018 | Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
| JOURNAL OF CLINICAL INVESTIGATION |
| 2018 | Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer | BRITISH JOURNAL OF CANCER |
| 2018 | DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer
| CANCERS |
| 2018 | Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer.
| SCIENTIFIC REPORTS |
| 2018 | Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis | CANCER RESEARCH |
| 2018 | Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer | GYNECOLOGIC ONCOLOGY |
| 2018 | An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
| CANCER RESEARCH AND TREATMENT |
| 2018 | Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
| CANCER RESEARCH AND TREATMENT |
| 2018 | Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2
| CANCER RESEARCH AND TREATMENT |
| 2017 | The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis
| BIOMED RESEARCH INTERNATIONAL |
| 2017 | API5 induces cisplatin resistance through FGFR signaling in human cancer cells
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2017 | HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells | CANCER RESEARCH |
| 2017 | Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer | ANTICANCER RESEARCH |
| 2017 | Association of isolated single umbilical artery with perinatal outcomes: Systemic review and meta-analysis
| Obstetrics & Gynecology Science |
| 2017 | Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study | CANCER |
| 2017 | API5 confers cancer stem cell-like properties through the FGF2-NANOG axis | ONCOGENESIS |
| 2016 | Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer
| ONCOTARGET |
| 2016 | Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
| ONCOTARGET |
| 2016 | Relationship Between Gonadotropin-Releasing Hormone/Gonadotropin-Releasing Hormone Receptor Signaling and Progesterone Receptors in Human Trophoblasts | JOURNAL OF REPRODUCTIVE MEDICINE |
| 2016 | Over-expression of BMI1 is associated with favorable prognosis in cervical cancer
| INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY |
| 2016 | Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients
| JOURNAL OF TRANSLATIONAL MEDICINE |
| 2016 | Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women | GYNECOLOGIC ONCOLOGY |
| 2016 | Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea
| BMC CANCER |
| 2016 | Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
| MEDICINE |
| 2016 | Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
| ONCOTARGET |
| 2016 | Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
| YONSEI MEDICAL JOURNAL |
| 2015 | Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis
| ONCOTARGET |
http://orcid.org/0000-0001-6599-7065
(34771509800)
